Heartflow, Inc. Common Stock
HTFL
Rang in aandelen
#3536
HeartFlow, Inc. operates as a global medical technology firm, specializing in... HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Aandeelprijs
$55.65
Laatst gesynchroniseerd: 2026-10-21
Marktkapitalisatie
$4.84B
Verandering (1 dag)
0.11%
Verandering (1 jaar)
41.57%
Land
US
Handel Heartflow, Inc. Common Stock (HTFL)
Categorie
Healthcare
Koersgeschiedenis voor Heartflow, Inc. Common Stock (HTFL)
Hoogste slotkoers: $50.64 op 2026-10-01
Laagste slotkoers: $30.90 op 2025-08-01
Laagste slotkoers: $30.90 op 2025-08-01
Koersgeschiedenis van Heartflow, Inc. Common Stock van 2025 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 14.69% |
| 2025 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $68.99 | -9.39% |
US
|
|
| $135.56 | -26.56% |
AU
|
|
| $62.83 | 90.74% |
US
|
|
| $67.71 | -20.60% |
US
|
|
| $76.26 | 521.98% |
US
|
